Post-translational cleavage product of proglucagon, released from intestinal L cells in response to nutrient sensing. Activates GLP-1R on pancreatic β-cells (glucose-dependent insulin release), α-cells (glucagon suppression), hypothalamus (satiety), and gastric smooth muscle (slowed emptying). Rapidly inactivated by DPP-4 cleavage at the N-terminus — hence all clinical GLP-1 analogs carry Aib or other DPP-4-resistant substitutions.
Half-Life & Elimination Curve (PO: 2m)
Elimination (PO)
0×t½0h100%
1×t½2m50%
2×t½5m25%
3×t½7m12.5%
4×t½9m6.3%
5×t½11m3.1%
Elimination t½2m (PO)
Rate Constant (ke)18.2 h⁻¹
Clearance (CL)128 L/h
97% Washout (5×t½)11m
Pharmacokinetic Parameters
Oral (PO): Volume of Distribution (Vd): 7 L [PMID 14988249]